Genta Announces Results Of AGENDA Phase 3 Trial Of Genasense(R) In Patients With Advanced Melanoma 7:02 am ET 11/16/2009- Dow Jones <a href="http://ih.advfn.com/p.php?pid=nmona&cb=1258374077&article=40372984&symbol=NB%5EGETA" rel="nofollow" target="_blank">http://ih.advfn.com/p.php?pid=nmona&cb=1258374077&article=40372984&symbol=NB%5EGETA</a>